EasySeq Full-length 16S Library Prep Kit
Commercial- Indications
- Microbiology & Infectious Disease
Company intelligence / Profile preview
NimaGen is a Dutch biotechnology company that develops and manufactures advanced molecular biology tools for DNA sequencing. The company's core innovation is the patented Reverse Complement PCR (RC-PCR) technology, which enables a streamlined, single-step workflow for Next-Generation Sequencing (NGS) library preparation. This technology significantly reduces manual labor and contamination risks by combining target amplification and sequencing adapter tagging in a closed-tube system. NimaGen offers a comprehensive portfolio of products, including EasySeq NGS kits and high-quality reagents for Sanger sequencing, such as dye terminator removal systems. Their solutions are widely utilized in clinical diagnostics, forensic science, and agricultural biotechnology to enhance the speed and accuracy of genetic testing.
10 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NimaGen.